ONCOTHERM.BIZ
OncothermNo description found
http://www.oncotherm.biz/
No description found
http://www.oncotherm.biz/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
Oncotherm GmbH
Janina Leckler
Belgis●●●●●●llee 9
Tro●●●orf , 53842
Germany DE
View this contact
Oncotherm GmbH
Janina Leckler
Belgis●●●●●●llee 9
Tro●●●orf , 53842
Germany DE
View this contact
1&1 Internet AG
Hostmaster EINSUNDEINS
Brau●●●●. 48
Kar●●●uhe , 76135
Germany DE
View this contact
1&1 Internet AG
Hostmaster EINSUNDEINS
Brau●●●●. 48
Kar●●●uhe , 76135
Germany DE
View this contact
BUY YOUR DOMAIN
1&1 INTERNET AG BATCHCSR
WHOIS : whois.neulevel.biz
REFERRED :
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
0
SITE IP
212.227.247.152
LOAD TIME
0 sec
SCORE
6.2
Oncotherm | oncotherm.biz Reviews
https://oncotherm.biz
<i>No description found</i>
Home Page
Focusing on scientific discovery and innovation in targeted therapy and immuno-oncology to save human lives:. Cancer is the second most common cause of death in the US, exceeded only by heart disease. One of every four deaths in the United States is due to cancer. The American Cancer Society estimates that in 2014, about 1,665,540 Americans were diagnosed with invasive cancer, and 585,720 Americans died of this disease. The company currently has three preclinical programs:. Preclinical studies of these d...
Oncotherex | Cancers du sein et de l'ovaire
Cancers du sein et de l'ovaire. Cancers du sein et de l'ovaire. Oncotherex est spécialisée dans la mise en culture de tumeurs du sein et de l'ovaire permettant de tester l'efficacité thérapeutique de molécules innovantes. En savoir plus sur Oncotherex. Vous êtes une start-up, un laboratoire académique ou une entreprise pharmaceutique et vous souhaitez tester des molécules innovantes, venez vite découvrir nos offres. Oncotherex propose de nombreux tests sur ses tumeurs du sein et de l'ovaire. Bienvenue su...
OncoTherics News
Latest news and events from Oncotherics. Wednesday, 17 December 2014. OncoTherics signs collaboration agreement with University of Cambridge. OncoTherics has signed a collaboration agreement with the University of Cambridge to progress a series of novel preclinical investigations using OCT1002 in Pancreatic Tumour models. The investigations will augment OncoTherics formal preclinical studies, providing useful additional information about OCT1002 in Pancreatic Cancer. Wednesday, 16 July 2014. Weiss Medall...
Oncotherix / InCell-RT™
Oncotherix™ is a clinical stage oncology company developing InCell-RT™. Herapy) for the treatment of locally-advanced cancers. InCell-RT is DNA-ligated nanometer-scale intracellular radiotherapy locally administered via catheter-based infusion systems. Oncotherix is developing InCell-RT as a safer and more effective treatment for numerous locally-advanced cancers, starting with recurrent ovarian cancer and high grade glioma brain cancer. Therapeutic Advantages of InCell-RT. 12635 E. Montview Blvd.
Oncotherm
Oncotherm
Oncotherm
Oncotherm
Oncothermia
Oncothermia
